| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |